Presented by
IR Magazine & Sentieo
Webinar – Opportunities and challenges for pharma and biotech companies in 2021
About this talk
With a new administration in Washington, DC, we will see changes across government agencies – including the SEC and the Food and Drug Administration – as well as the potential for further tweaks to the US healthcare system. These factors, along with the Covid-19 vaccine rollout, raise a host of opportunities and challenges for pharmaceutical and biotechnology companies during 2021. In addition, the whole market continues to try to piece together the events of late January involving GameStop, AMC Entertainment and others, to ask whether it can happen again.
In this webinar we will examine how pharma and biotech companies can prepare for the year ahead – both in terms of regulatory changes and corporate access – and learn about retail IR strategies.
IR Magazine has partnered with Sentieo to deliver you this webinar. IR Magazine and Sentieo will process your personal data for purposes connected with your attendance at the webinar and may send you marketing communications and information that may be of interest to you, as permitted under applicable law. You may choose to unsubscribe at any time by email with ‘unsubscribe’ in the subject line or by clicking on the “unsubscribe” link in any email from us or Sentieo. Your data will be processed in accordance with IR Magazine’s privacy policy: www.irmagazine.com/privacy and Sentieo‘s privacy policy: www.sentieo.com/privacy-policy/.
More from this channel
Upcoming talks (3)
On-demand talks (121)
Subscribers (21346)
ABOUT IR MAGAZINE
IR Magazine is a publication of IR Media Group, a business media company renowned for its magazines, websites, events and research.
Originally launched in 1988 by the Economist Group, IR Magazine is essential reading for executives around the world and helps investor relations professionals globally achieve more in their IR programmes, benchmark their efforts and connect to their peers in the IR community. For more information, please visit www.irmagazine.com
This webinar series is part of our commitment to providing ongoing education to the IR community. Working with various experts in their field, join the thought-leadership discussions on key issues affecting investor relations, guides to best practice and much, much more.
ABOUT CORPORATE SECRETARY
Corporate Secretary was founded in 2002 to help corporate secretaries and other governance professionals develop a deeper understanding of their roles and become more effective in them at a time when publicly listed companies’ regulatory compliance requirements began to escalate amid a series of high-profile corporate accounting scandals.
Corporate Secretary is a digital and print platform, providing a forum where governance experts and service providers can share their experience, insights and best practice recommendations on a wide range of critical issues, from corruption, internal investigations, e-discovery and records management to succession planning, executive compensation, proxy actions and shareholder engagement. Corporate Secretary is independently owned and today continues to serve a vital role in highlighting the achievements and expertise of a group of people who work outside the spotlight and are often isolated as the only individuals in their organizations focusing on these complex matters.